Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment | PLOS ONE
Levofloxacin in the treatment of ventilator-associated pneumonia - Clinical Microbiology and Infection
Short- vs Long-Duration Antibiotic Regimens for Ventilator-Associated Pneumonia - CHEST
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial - The Lancet Infectious Diseases
Diagnosis and Treatment of Ventilator-Associated Pneumonia - CHEST
Management of Ventilator-Associated Pneumonia - Clinics in Chest Medicine
Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials | Critical Care | Full Text
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment | PLOS ONE
Missouri Society of Health-System Pharmacists - Diagnosis and Treatment of Adults with Community-acquired Pneumonia: 2019 Clinical Practice Guidelines
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia | European Respiratory Society
JCM | Free Full-Text | Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia | HTML
Ventilator-associated pneumonia in adults: a narrative review | SpringerLink
Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study | Annals of Intensive Care | Full Text
Empiric treatment VAP (adults) - UpToDate
Update on ventilator-associated pneumonia | F1000Research
Ventilator Associated Pneumonia (VAP) - EMCrit Project
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia | European Respiratory Society
JCM | Free Full-Text | Ventilator-Associated Pneumonia and PaO2/FIO2 Diagnostic Accuracy: Changing the Paradigm?
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation - The Lancet Respiratory Medicine
Strategies to reduce non-ventilator-associated hospital-acquired pneumonia: A systematic review - Infection, Disease & Health
Phase 3 Study for Ventilator-Associated Pneumonia (VAP)
The Prevention of Ventilator-Associated Pneumonia | NEJM
The Vexing Problem of Ventilator-Associated Pneumonia: Observations on Pathophysiology, Public Policy, and Clinical Science | Respiratory Care
Grand Rounds Recap 5.30.18 — Taming the SRU
Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention | Clinical Microbiology Reviews
REBEL Cast Episode 29: IDSA Pneumonia Update - REBEL EM - Emergency Medicine Blog
20749 Annihilating ventilator-associated pneumonia with a respiratory therapy emphasis on oral care handout
